AlphAIalphai — Financial news for AI agents
finanznachrichten.deAUG 74 min read$ULBI

Ultralife Corporation Reports Second Quarter Results

Ultralife Corporation (NASDAQ: ULBI) reported Q2 2026 results for the quarter ended June 30. Sales fell to $47.9 million from $48.6 million in Q2 2025. Gross profit rose to $13.9 million, with gross margin 28.9%. GAAP EPS was $0.15 vs $0.05, and adjusted EBITDA was $6.1 million vs $4.1 million. Backlog rose to $117.5 million.

Original reporting
finanznachrichten.de
Published Aug 7, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 11:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$ULBI
Bullish
medium confidence
Mentioned
$ULBI
Relevance
9/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$ULBIBullishMed
01

Why it matters

Q2 results show YoY revenue down slightly, but profitability improved materially: gross margin rose to 28.9% (26.6% excluding the IEEPA refund), GAAP EPS increased to $0.15, and adjusted EBITDA rose to $6.1M. Backlog reached $117.5M, the highest in company history, which can support future production and revenue conversion.

02

Market read

Traders can reassess ULBI’s earnings trajectory using the fresh margin, EPS, adjusted EBITDA, and record backlog figures, plus segment-level growth and cost drivers.

03

What to watch

Operating expenses rose due to new product development and one-time litigation/consulting costs, so investors may need to separate sustainable margin gains from temporary cost and tariff effects.

Relevance 9/10Novelty 8/10Timing: earnings release and conference call today (Aug 7, 2026)

Background

Ultralife operates two segments, Battery & Energy Products and Communications Systems, and is executing manufacturing-efficiency initiatives plus new product development for government/defense programs.

Company-level read

Ticker impact

$ULBIBullishMedium confidence
Context

Ultralife reported Q2 revenue of $47.9M, GAAP EPS $0.15, and gross margin up to 28.9% with backlog hitting a record $117.5M.

Expected impact

Likely positive bias for ULBI on earnings-day positioning, with follow-through dependent on whether investors focus on margin quality and backlog conversion.

Evidence & confidence

The release provides multiple fresh datapoints (GAAP EPS, gross margin ex-refund, adjusted EBITDA, and record backlog) that can re-rate expectations, though the top-line decline tempers the signal.

Market effects

Sector

Signals improving profitability in defense-linked communications and battery systems, potentially supportive for small-cap defense electronics sentiment.

Regional

Limited direct regional spillover; primarily company-specific.

Global

References government/defense programs and international operations, but no new global macro or policy shock beyond tariff/refund context.

Counterpoint

What could challenge this read

Gross margin improvement is partly attributed to a net IEEPA refund; if that benefit is non-recurring, the earnings power may be overstated.

Key entities

  • company
    Ultralife Corporation

    NASDAQ-listed company reporting Q2 2026 results, margin improvement initiatives, and record backlog.

  • business_segment
    Communications Systems segment

    Reported 39.3% YoY revenue growth to $3.8M and higher gross margin driven by sales mix.

  • business_segment
    Battery & Energy Products segment

    Reported revenue decline to $44.2M but improved gross margin to 28.3% aided by favorable mix and IEEPA refund.

Read at source← All news

Related articles

AUG 8
$ULBIMedAI 8/10

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

fool.com6 min
AUG 7
$ULBIMed

ULTRALIFE CORP (ULBI): Results of Operations and Financial Condition

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1001163.htm EXHIBIT 99.1 ex_1001163.htm Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following re

SEC EDGAR 8-K6 min
AUG 8
$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

yahoo.com6 min
AUG 8
$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

yahoo.com6 min
AUG 8
$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

yahoo.com5 min
AUG 8
$GPNMed

Global Payments Q2 Earnings Call Highlights

Global Payments (NYSE:GPN) reported Q2 results and discussed its Worldpay integration and Genius point-of-sale rollout. Management guided for about 4.5% revenue growth in 2H, margins near 43%, and cited drivers including sales-force ramp and enterprise go-lives. Q2 adjusted net revenue by segment: SMB $1.51B, Enterprise $838M, Platforms $628M. Adjusted free cash flow was $687M; net leverage just below 3.5x.

yahoo.com7 min